Mylan NV (NASDAQ:MYL) Analyzing Financial Health

Mae Love
December 7, 2017

Princeton Port Strategies Group Incorporated Lc accumulated 0% or 10,000 shares. 300 are held by Nelson Roberts Ltd.

Publicly-traded company Mylan N.V. (NASDAQ:MYL) had a closing price of $37.44 yesterday. Doliver Capital Advisors LP purchased a new stake in shares of Mylan during the 2nd quarter worth about $201,000. Institutional investors and hedge funds own 73.86% of the company's stock. The stock has a market cap of $20,448.95, a P/E ratio of 8.11, a price-to-earnings-growth ratio of 2.09 and a beta of 1.38.

The SMA20 for the stock is at 0.23 percent, SMA50 stands at 1.71 percent, while SMA200 is 0.19 Percent, according to Finviz reported data. Dai Ichi Life Insurance Company Ltd now owns 26,002 shares of the company's stock worth $1,009,000 after acquiring an additional 107 shares during the period. Mylan N.V. (MYL) has an operating margin of 11.20%. It has underperformed by 24.43% the S&P500. Finally, Eagle Global Advisors LLC purchased a new stake in shares of Mylan during the 2nd quarter worth about $205,000. It also increased its holding in Merck & Co Inc (NYSE:MRK) by 272,500 shares in the quarter, for a total of 698,195 shares, and has risen its stake in Neuroderm Ltd.

Ball State Upsets Notre Dame
The Fighting Irish entered the game as almost 20-point favorites over their in-state opponent but instead dropped to 3-1 at home. Notre Dame came out hot in the second half, hitting its first six shots to take the lead, but the Cardinals stood their ground.

Saga shares dive by 25% on profits warning
Saga's travel segment "continues to trade well" and is expected to be strongly ahead of the prior year. The company floated in 2014 at an offer price of 185p-per-share.

Bigg Boss 11: Arshi Khan becomes the new captain of the house
But looks like things didn't go well as they had planned and this has led to an intense fight between Luv and Priyank. Shilpa doesn't manages to park the pram on time, and since she had Priyank's doll, he gets out of the captaincy race.

Research analysts at UBS now has a $46.0 target price on Mylan Inc (NASDAQ:MYL). The co's performance for 6 months was moved down of -1.35%, 1-year performance stands at 5.80% and year to date showing reduced performance of -0.08%. It also reduced Yelp Inc (NYSE:YELP) stake by 1.66 million shares and now owns 1.00M shares.

More recent Mylan N.V. (NASDAQ:MYL) news were published by: which released: "FDA OKs Mylan's biosimilar of Roche cancer drug Herceptin" on December 01, 2017. Eqis Cap Mgmt has 5,251 shares for 0.01% of their portfolio. Guggenheim restated a "neutral" rating on shares of Mylan in a research report on Friday, March 3rd. Mylan's revenue for the quarter was down 2.3% compared to the same quarter last year. analysts anticipate that Mylan will post 4.56 EPS for the current year. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company's stock. Therefore 63% are positive. Mylan has a 1-year low of $29.39 and a 1-year high of $45.87. The company now has an average rating of "Buy" and an average target price of $41.49. Mylan Inc. had 55 analyst reports since July 27, 2015 according to SRatingsIntel. BTIG Research has "Buy" rating and $85 target. The stock of Mylan N.V. (NASDAQ:MYL) earned "Hold" rating by RBC Capital Markets on Monday, June 12. Mizuho reaffirmed a buy rating and issued a $37.00 target price (down previously from $53.00) on shares of Mylan in a research report on Sunday, August 20th. The stock of Mylan N.V. (NASDAQ:MYL) earned "Hold" rating by RBC Capital Markets on Friday, October 20. Zacks has "Hold" rating and $57 target. The company was initiated on Wednesday, October 26 by Mizuho. BMO Capital Markets reiterated a buy rating and issued a $45.00 price objective on shares of Mylan in a report on Friday, September 29th. Swiss National Bank now owns 1,661,842 shares of the company's stock worth $64,513,000 after buying an additional 50,100 shares during the period. Finally, ValuEngine raised Mylan from a "hold" rating to a "buy" rating in a report on Monday, October 2nd. The rating was maintained by UBS with "Buy" on Monday, October 10.

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with our FREE daily email newsletter.

Other reports by

Discuss This Article